TECELRA

STN: 125789
Proper Name: afamitresgene autoleucel
Tradename: TECELRA
Manufacturer: Adaptimmune LLC
Indication:

Treatment of adults and pediatric patients 12 years of age and older with unresectable or metastatic synovial sarcoma who have received prior chemotherapy, are HLAA* 02:01P, -A*02:02P, -A*02:03P, or -A*02:06P positive and whose tumor expresses the MAGEA4 antigen as determined by FDA-approved or cleared companion diagnostic devices.

Product Information